A Trial of Dalotuzumab in Combination With Irinotecan Versus Cetuximab and Irinotecan for Participants With Metastatic Rectal Cancers (mRC) (MK-0646-025)
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Irinotecan
Related studies linked through entity extraction aliases.
Irinotecan for Previously Treated, Advanced, Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of MLN8237 in Combination With Irinotecan and Temozolomide
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical Trial
- Status
- COMPLETED
- Phase
- PHASE3
A Translational Study of Bevacizumab in Participants With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE4
FOLFIRI or mFOLFOX6 in Adjuvant Chemotherapy in Advanced Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Preoperative Folfirinox, Radiation Therapy for Resectable Adenocarcinoma of the Pancreas
- Status
- COMPLETED
- Phase
- PHASE2
Xeloxiri as First-line Treatment in Patients With Advanced Unresectable Pancreatic Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Research Study of IV Vitamin C in Combination With Irinotecan vs Irinotecan Alone for Advanced Colorectal CA
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Metformin in Children With Relapsed or Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Randomized Efficacy Study of TPI 287 to Treat Primary Refractory or Early Relapsed Neuroblastoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Phase II Study of FOLFOXIRI in Patients With Locally Advanced or Metastatic Biliary Tract Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Efficacy and Safety of Simtuzumab (SIM) With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Genotype-driven Phase I Study of Irinotecan Administered in Neoadjuvant Chemoradiotherapy in Patients With Stage II/III Rectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
Multimodal Molecular Targeted Therapy to Treat Relapsed or Refractory High-risk Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE2
A Safety Study of MM-121 With Cetuximab and Irinotecan in Patients With Advanced Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Chemotherapies Associated With Targeted Therapies on the Resection Rate of Hepatic Metastases
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy of Chemotherapy, Associated to Either Cetuximab or Bevacizumab, in KRAS Wild-type Metastatic Colorectal Cancer Patients With Progressive Disease After Receiving First-line Treatment With Bevacizumab
- Status
- COMPLETED
- Phase
- PHASE2
FOLFIRINOX Plus PF-04136309 in Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE1